目的探讨人工肝支持系统对重型肝炎的疗效。
Objective To study the efficacy of artificial liver support system in treatment of severe hepatitis.
体外肝细胞培养是生物制药和人工肝支持系统的技术基础。
Cultured cells are the basic element of biologic pharmacy and artificial liver system.
目的评价人工肝支持系统中血浆置换治疗重型肝炎的疗效。
Objective To evaluate the curative effect of plasma-exchange therapy for severe hepatitis in artificial liver system.
目的：探讨人工肝支持系统(ALSS)对重型肝炎的疗效。
Objectives Peobing the curing effects of artificial liver supporting systems (ALSS) treatment of fatal hepatitis.
目的观察人工肝支持系统治疗重型肝病、肝衰竭的疗效及影响因素。
Objective To discuss the incidence, prevention and treatment of the complication of artificial liver support system(ALSS)in the treatment of fatal hepatitis.
目的评估膦甲酸钠联合人工肝支持系统治疗重型乙型肝炎的临床价值。
Objective To estimate the clinical value of combination of PFA with ALSS in the treatment of SHB.
结论人工肝支持系统联合内科常规方法治疗肝功能衰竭疗效优于常规治疗。
Conclusion the effectiveness of an artificial liver support system in addition to routine medicinal therapy in treating liver failure is better than that of routine therapy.
目的探讨人工肝支持系统(ALSS)治疗重型肝炎的护理问题和护理措施。
Objective Make an inquiry into the nursing problems and nursing methods of artificial liver supporting systems (ALSS) treatment of fatal hepatitis.
目的探讨人工肝支持系统(ALSS)治疗重型病毒性肝炎(重型肝炎)的疗效。
Objective To observe the efficacy of artificial liver support system (ALSS) in the treatment of severe hepatitis.
目的研究冷冻复温后猪肝细胞在生物型人工肝支持系统（BALSS）中的生存状态。
Objective To study the living status of cryopreserved porcine hepatocytes in biological artificial liver support system (BALSS).
目的：探讨人工肝支持系统(ALSS)治疗重症肝炎的疗效及其影响ALSS疗效的因素。
Objective to discuss the curative effect and influencing factor of ALSS curative effect of artificial liver support system (ALSS) treats the severe liver disease.
生物人工肝支持系统(BALSS)是治疗肝功能衰竭的有效方法，已成为国内外的研究热点。
Bioartificial liver support system (BALSS) is an efficient method to treat acute liver failure, which has been a research focus all over the world.
结论所建混合生物人工肝支持系统对肝衰竭有明显的肝支持作用，可作为重型肝炎的有效治疗手段。
Conclusions the hybrid artificial liver support system has prominent liver support effects for hepatic failure, which can be regarded as an efficient measure for the treatment of severe hepatitis.
治疗后，试验对象生命体征稳定，代谢支持作用明显。结果表明：构建的生物人工肝支持系统安全、稳定、有效。
After treatment, life signs of subjects were stable and the metabolic support was obvious, which indicated: the Bioartificial Liver support System which we constructed was safe, stable and efficient.
目的：观察teca型组合型人工肝支持系统(HALSS)治疗急性肝功能衰竭(alf)患者的有效性和安全性。
Objective: to assess the efficacy and safety of type TECA hybrid artificial liver support system (HALSS) to treat patients with acute liver failure (ALF).
目的通过观察人工肝支持系统对重型肝炎血清降钙素原（PCT）水平的影响，探讨PCT水平改变对重型肝炎临床转归的影响。
Objective To evaluate effect of artificial liver support system(ALSS) on blood procalcitonin(PCT) level and clinical prognosis in patients with hepatitis gravis.
目的通过观察终末期肝病模型(MELD)在终末期肝病预后预测中的作用，探讨其在临床的应用价值及人工肝支持系统在终末期肝病治疗中的效果。
Objective: To study the practical use of model end-stage liver disease (MELD) on clinic and the role of artificial liver support system (ALSS) on end-stage liver disease.
目的通过观察终末期肝病模型(MELD)在终末期肝病预后预测中的作用，探讨其在临床的应用价值及人工肝支持系统在终末期肝病治疗中的效果。
Objective: To study the practical use of model end-stage liver disease (MELD) on clinic and the role of artificial liver support system (ALSS) on end-stage liver disease.
应用推荐